Industry-funded public relations firm behind Food and Drug Administration web site

Government reform orgs. deliver news on major events within their areas of expertise.
From: Center for Media and Democracy

Pay No Attention to the Industry-Funded Group Behind the Website

Source: Center for Science in the Public Interest, September 15, 2008

To develop its new website that tries to help the public understand direct-to-consumer drug ads, the U.S. Food and Drug Administration (FDA) "turned to a nonprofit front group erected by Shaw Science Partners, a public relations firm that specializes in launching new drugs," according to the Center for Science in the Public Interest (CSPI). EthicAd, the nonprofit behind the FDA site, is funded by Shaw Science and its own board members. Shaw Group founder Michael Shaw admitted that "if not all, almost all" of EthicAd's funders "do work for industry." EthicAd also "shares the same physical address as Shaw Science Partners." CSPI gives a negative review of the FDA site, calling it "jargon-filled" and lacking advice on how to evaluate messages about drug side effects, among other consumer topics. CSPI is calling on the FDA "to scuttle the web site, to terminate its relationship with the drug companies' PR firm, and to seek out advice from leading physicians, pharmacists, or consumer groups."

>All Things Reform Mobile: allthingsreform.mofuse.mobi >Capitol Switchboard: 202-224-3121 (not toll-free) >US House/Senate Mobile: bit.ly/members >Contact your reps tips: bit.ly/dear >Shortened All Things Reform URL: bit.ly/dw

Related articles by Zemanta

• Tell your congress members to support strong whistleblower rights for government employees

Help pass drug safety law

Take on the powerful pharmaceutical drug industry lobby! State affiliates of U.S. PIRG, a public interest group, are running a internet grassroots campaign to pass a drug safety bill. Here is an opportunity for you to help get President Bush to sign it into law (you don't have to live in this affiliate's state to participate). Here's their message:

The drugs in your medicine cabinet will soon be safer because Congress passed strong drugs safety legislation.The House and Senate hammered out an agreement on a final drug safety bill earlier this week and the House passed it on Wednesday. The Senate will pass the identical bill today, but the President, who has sided with the pharmaceutical industry and their goal of weak drug safety reforms, still must sign the bill.The pharmaceutical industry has opposed many of the safety reforms in the bill, but in the end there were too many headlines about dangerous drugs and Congress had to act. We're glad they did.Our top drug safety priority passed. Drug makers must release the results of their safety studies on-line. No more hiding unflattering or dangerous results. This will help patients and doctors figure out if the drug's risk is worth its benefits.
The bill also authorizes the FDA to issues fines of up to $10 million for drug makers who fail to complete follow-up drug safety studies. Drug makers used to routinely ignore follow-up studies. The threat of this stiff fine should get their attention.The bill includes other good safety provisions such as strengthening conflicts-of-interest rules at the FDA and increasing by $225 million the budget for follow-up drug safety studies. These studies are extremely important for people taking drugs for years at a time to control chronic conditions.Together we can make sure this legislation is signed into law. Join me in telling President Bush to sign the strong drugs safety legislation passed by Congress.
To take action, click on the link below or paste it into your browser: https://www.uspirg.org/action/health-care/strong-bill?id4=ES
Sincerely, Dr. Matthew Tejada TexPIRG Advocate, MatthewT@texpirg.org, http://www.texpirg.org/
P.S. Thanks again for your support. Please feel free to share this e-mail with your family and friends.

The people deserve safe drugs again

A drug safety bill is entering the conference stage by both houses before it will be sent to our President for his signature. It concerns the Food and Drug Administration (FDA), the regulator of prescription drugs. It corrects some of the agency's failures and makes it more accountable to the people.

We have heard the stories-- Vioxx, Paxil and now Oxycontin and Avandia and other dangerous drugs passing the FDA on their way to peoples' medicine cabinets. Used to be, we often complained that the FDA took too long to approve drugs, such as those for cancer; however, our FDA was very thorough in certifying the safety of drugs before they hit the market.

With today's passing in the House of a strong ethics and lobbying bill, let's continue this strong reform of government by sending President Bush a good drug safety bill as well!